Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer

Gynecologic Oncology

Volumn 107, Issue 3, 2007, Pages 482-486

  Axtell, Allison E ^a   Kelley, Joseph L ^a   Fader, Amanda Nickles ^a   Gupta, Dilip ^b   Schwartz, Benjamin ^a   Comerci, John T ^a   Lin, Yan ^b   Weiand, Samuel ^b   Gallion, Holly H ^a   Kanbour Shakir, Amal ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endometrial cancer; Lymph node metastasis; Lymphadenectomy; Surface area involvement; Surgical staging

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; MYOMETRIUM; PRIORITY JOURNAL; SEROSA;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 36349030231     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.08.004     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts & Figures 2005.
2. Creasman W.T., Morrow P., Bundy B.N., et al. Surgical pathologic spread patterns of endometrial cancer. Cancer 60 (1987) 2035-2041
3. Kirby T.O., Leath C.A., and Kilgore L.C. Surgical staging in endometrial cancer. Oncology 20 (2006) 45-50
4. McMeekin D.S., Lashbrook D., Gold M., et al. Analysis of FIGO stage IIIC endometrial cancer patients. Gynecol Oncol 81 (2001) 273-278
5. McMeekin D.S., Lashbrook D., Gold M., et al. Nodal distribution and its significance in FIGO stage IIIC endometrial cancer. Gynecol Oncol 82 (2001) 375-379
6. Lurain J.R., Rice B.L., Rademaker A.W., et al. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78 (1991) 63-69
7. Mariani A., Webb M.J., Rao S.K., Lesnick T.G., and Podratz K.C. Significance of pathologic patterns of pelvic lymph node metastasis in endometrial cancer. Gynecol Oncol 80 (2001) 113-120
8. Nelson G., Randall M., Sutton G., et al. FIGO stage IIIC endometrial carcinoma with metastasis confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 75 (1999) 211-214
9. Mariani A., Dowdy S.C., Cliby W.A., et al. Efficacy of systemic lymphadenectomy and adjuvant radiotherapy in node positive endometrial cancer patients. Gynecol Oncol 101 (2006) 200-208
10. Bristow R.E., Zahurak M.L., Alexander C.J., Zellars R.C., and Montz F.J. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13 (2003) 664-672
11. Cragun J.M., Havrilesky L.J., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23 (2005) 3668-3675
12. Pavelka J.C., Ben-Shachar I., Fowler J.M., et al. Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 95 (2004) 588-592
13. Franchi M., Ghezzi F., Riva C., et al. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol 78 (2001) 232-237
14. Schink J.C., Rademaker A.W., Miller D.S., and Lurain J.R. Tumor size and endometrial cancer. Cancer 67 (1991) 2791-2794
15. Shah C., Johnson E.B., Everett E., et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 99 (2005) 564-570
16. Mariani A., Webb M.J., Keeney G.L., et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 182 (2000) 1506-1519
17. Schink J.C., Rademaker A.W., Miller D.S., and Lurain J.R. Tumor size in endometrial cancer. Cancer 67 (1991) 2791-2794
18. Frumovitz M., Singh D.K., Meyer L., et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95 (2004) 463-468
19. Mitchard J., and Hirschowitz L. Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens. Histopathology 42 (2003) 372-378
20. Ben-Shachar I., Pavelka J., Cohn D.E., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 105 (2005) 487-493
21. Quinlivan J.A., Petersen R.W., and Nicklin J.L. Accuracy of frozen section for the operative management of endometrial cancer. BJOG 108 (2001) 798-803
22. Nakao Y., Yokoyama M., Hara K., et al. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 102 (2006) 343-347
23. Mariani A., Sebo T.J., Katzmann J.A., et al. Endometrial cancer: can nodal status be predicted with curettage?. Gynecol Oncol 96 (2005) 594-600
24. Bidus M.A., Risinger J.I., Chandramouli G.V., et al. Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray. Clin Cancer Res 12 (2006) 83-88